Breaking News – FDA Approves another New Treatment for Late Stage Advanced Prostate Cancer – Xtandi (MDV3100)
The U.S. Food and Drug Administration today, August 31, 2012 approved Xtandi® (MDV3100) (enzalutamide) capsules to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy [...]
A FDA Approval for Zytiga Before Chemotherapy – On the Horizon
On Wednesday, Johnson & Johnson said that the FDA will conduct a fast review of Zytiga as a treatment for men with advanced prostate cancer who have not received chemotherapy. The Food and Drug Administration [...]
Early Access Program Needs Your Help – Share Your Experiences to Insure A Continuing Program
Dr. Moyad has been the driving force behind getting the Early Access Program for drugs to treat advanced prostate cancer. Along with the Early Access Committee he has arranged for an early access (before the [...]
Travel Notice
I wanted to let everyone know that over the next two weeks my posts might become few and far between. Iaa am traveling with my family in Alaska where my ability to find either internet [...]
Four New Sites Added to the MDV3100 (Enzalutamide) Early Access Trial
The Early/Expanded Access Committee has informed me that four additional sites have been added to the trial so there are now 23 States that have an expanded access trial of MDV3100 available to men with [...]
So, You Think You Are Safe in Your Doctor’s Office?
When the press discusses medical mistakes they are usually referring to mistakes made in a hospital, but guess what, mistakes are often made in a doctors office. These mistakes are not counted in the statistics [...]